Hot Stock on the Radar: Helios and Matheson Analytics Inc. (NASDAQ:HMNY), Nucor Corporation (NYSE:NUE)

Helios and Matheson Analytics Inc. (NASDAQ:HMNY)

The shares of Helios and Matheson Analytics Inc. (NASDAQ:HMNY) started off the last trading session with the price of $3.4 while closing the day with the price of $3.37. The shares of Helios and Matheson Analytics Inc. (NASDAQ:HMNY) Fell -2.03% with the Loss of -0.03 points.

The shares of Helios and Matheson Analytics Inc. (NASDAQ:HMNY) traded with the day volume of 2.92 Million shares whereas its average trading volume is 6.05 Million.

While analyzing the past performance of the stock we can see that the shares of Helios and Matheson Analytics Inc. (NASDAQ:HMNY) Loss -15.96% in the last week while Falling -28.9% in the last month. Past quarter performance shows the red light with -46.17%. The semi-annual and annual performance shows -3.16% and 27.17% respectively.

Some critical values of the shares of Helios and Matheson Analytics Inc. (NASDAQ:HMNY) to be discussed here are: the beta which shows the value at 1.56 while Average True Range of Helios and Matheson Analytics Inc. (NASDAQ:HMNY) demonstrate the value at 0.44. The weekly and monthly volatility of the shares of Helios and Matheson Analytics Inc. (NASDAQ:HMNY) are indicated at 9.32% and 7.61%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 24.83.

While studying the financial position of the shares of Helios and Matheson Analytics Inc. (NASDAQ:HMNY), we can see that the Market capitalization of the company is at 87.59 Million. The shares outstanding for the company is 25.99 Million and the shares float stands at 16.16 Million. The income of the company stand at -61400000 while the sales stand at 4.8 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -9.43, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 18.25, the Return on Asset ROA stood at -4.113 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at -0.175.


Nucor Corporation (NYSE:NUE)

Nucor Corporation (NYSE:NUE) started its previous trading session at $65.53 and closed at $64.2 showing a Fell of -1.73 Percent.

The Company traded with an average Volume of 2.96 Million whereas, its Day Volume stood at 2.91 Million.

Looking at the performance of the stock, Nucor Corporation (NYSE:NUE) Loss -4.93% in the last week in its shares price and -6.33% in the last month. Quarterly performance shows a green of 6.8 Percent while Semi-Annual and Annual performances shows a 18.3 and -0.73 percent respectively.

Beta for Nucor Corporation (NYSE:NUE) stands at 1.54 while the ATR (average true range) is at 1.91. The Stock’s Weekly and Monthly Volatility is 2.66% and 2.64% respectively showing a RSI value of 38.67.

While studying the financial position of the shares of Nucor Corporation (NYSE:NUE), we can see that the Market capitalization of the company is at 20.49 Billion. The shares outstanding for the company is 319.2 Million and the shares float stands at 316.58 Million.

The Company generated an income of 1.14 Billion and the sales of 20.25 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $3.55 a share. P/E (price to earnings) and P/S (price to sales) values are 18.08 and 1.01 respectively.

The Return on Assets stands at 0.082, ROE shows a value of 0.156 and ROI for Nucor Corporation (NYSE:NUE) is 0.108 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment